Huo Xiaokui, Yu Zhenlong, Zhao Feng, Chen Yang, Chen Peng, Xing Lina, Qiao Yanling, Peng Yulin, Tian Manman, Zhou Meirong, Wu Fan, Wang Yan, Wang Chao, Tian Xiangge, Lv Dongyue, Zhang Bo, Shi Lei, Ma Xiaochi, Ma Tonghui
Pharmaceutical Research Center, Second Affiliated Hospital, Dalian Medical University, Dalian, China.
Dalian Key Laboratory of Metabolic Target Characterization and Traditional Chinese Medicine Intervention, College of Basic Medical Sciences, Institute of Integrative Medicine, Dalian Medical University, Dalian, China.
J Hepatol. 2025 Mar;82(3):464-479. doi: 10.1016/j.jhep.2024.09.023. Epub 2024 Sep 24.
BACKGROUND & AIMS: Although water channel aquaporin-8 (AQP8) has been implicated in hepatic bile formation and liver diseases associated with abnormal bile flow in human and animal studies, direct evidence of its involvement in bile secretion is still lacking. This study aimed to determine the role of AQP8 in bile secretion and gallstone formation.
We generated various transgenic knock-in and knockout mouse models and assessed liver AQP8 expression by immunostaining and immunoblotting, hepatic bile secretion by cannulation of the common bile duct, cholesterol gallstone formation by feeding a high-fat lithogenic diet, and identified regulatory small molecules by screening the organic fractions of cholagogic Chinese herbs and performing biochemical characterization.
We identified a novel expression pattern of AQP8 protein in the canalicular membrane of approximately 50% of the liver lobules. AQP8-deficient mice exhibited impaired hepatic bile formation, characterized by the secretion of concentrated bile with a lower flow rate and higher levels of bile lipids than that of wild-type littermates. Aqp8 mice showed accelerated gallstone formation, which was rescued by AAV-mediated hepatic expression of AQP8 or AQP1. Moreover, we identified a small molecule, scutellarin, that upregulates hepatocyte AQP8 expression in vitro and in vivo. In Aqp8 mice, scutellarin significantly increased bile flow, decreased bile lipid concentrations, and prevented gallstone formation compared to Aqp8 mice. Molecular studies revealed that scutellarin promoted the ubiquitination and degradation of HIF-1α, a negative transcriptional regulator of AQP8, by disrupting its interactions with HSP90.
AQP8 plays a crucial role in facilitating water transport and bile dilution during hepatic bile formation, thereby mitigating gallstone formation in mice. Small-molecule intervention validated hepatocyte AQP8 as a promising drug target for gallstone therapy.
The incidence of gallstone disease is high, and current drug treatments for gallstones are very limited, necessitating the identification of novel drug targets for therapeutic development with universal applicability. To our knowledge, this is the first study to provide direct evidence that the hepatic water channel AQP8 plays a key role in bile dilution and gallstone formation. Modulation of hepatic water transport may provide a universal therapeutic strategy for all types of gallstone diseases.
尽管在人和动物研究中,水通道蛋白8(AQP8)已被证明与肝胆汁形成以及胆汁流动异常相关的肝脏疾病有关,但其参与胆汁分泌的直接证据仍然缺乏。本研究旨在确定AQP8在胆汁分泌和胆结石形成中的作用。
我们构建了多种转基因敲入和敲除小鼠模型,通过免疫染色和免疫印迹评估肝脏AQP8表达,通过胆总管插管评估肝脏胆汁分泌,通过喂食高脂致石饮食评估胆固醇胆结石形成,并通过筛选利胆中药的有机成分并进行生化特性分析来鉴定调节性小分子。
我们在约50%的肝小叶胆小管膜中发现了AQP8蛋白的一种新表达模式。AQP8基因敲除小鼠表现出肝脏胆汁形成受损,其特征是分泌的胆汁浓缩,流速低于野生型同窝小鼠,且胆汁脂质水平更高。Aqp8小鼠胆结石形成加速,通过腺相关病毒介导的肝脏AQP8或AQP1表达可使其得到挽救。此外,我们鉴定出一种小分子——灯盏花素,它在体外和体内均可上调肝细胞AQP8表达。在Aqp8小鼠中,与Aqp8小鼠相比,灯盏花素显著增加胆汁流量,降低胆汁脂质浓度,并预防胆结石形成。分子研究表明,灯盏花素通过破坏HIF-1α与HSP90的相互作用,促进了HIF-1α(AQP8的负转录调节因子)的泛素化和降解。
AQP8在肝脏胆汁形成过程中促进水转运和胆汁稀释方面发挥关键作用,从而减轻小鼠胆结石形成。小分子干预验证了肝细胞AQP8作为胆结石治疗有前景的药物靶点。
胆结石疾病的发病率很高,目前胆结石的药物治疗非常有限,因此需要确定具有普遍适用性的新型药物靶点用于治疗开发。据我们所知,这是第一项提供直接证据表明肝脏水通道AQP8在胆汁稀释和胆结石形成中起关键作用的研究。调节肝脏水转运可能为所有类型的胆结石疾病提供一种通用的治疗策略。